Klinik für Neurologie und Neurophysiologie

Neuroimmunology Ambassadors

Discover the cutting edge of neuroimmunology through the voices of tomorrow’s leaders and today’s experts. Our Rising Stars and Frontline Fighters share fresh perspectives, groundbreaking research, and clinical insights that are shaping the future of brain–immune science and patient care. 

Join us for our monthly lecture series to explore the evolving science and practice of neuroimmunology:

Lectures 2026

2026

Alexander Flügel, Prof MD (Göttingen): The role of the lung in CNS autoimmunity

Andreas Meisel, Prof MD (Berlin): Therapeutic Innovation in Myasthenia Gravis: Mechanistic Drivers and Future Trajectories

Christian Münz, Prof PhD (Zurich): How a human tumor virus might cause autoimmunity

Sarah Mundt, MD (Zurich): Mapping and Targeting Phagocytes to Decode Their Roles in CNS Inflammation

2025

Benjamin Segal, Prof MD (Columbus): Age-Associated Expansion of Natural IgM+ Fcrl5+ B1 Cell Clones: Drivers of Progressive MS and Targets for Therapy

Edoardo Galli, MD PhD (Basel): From High-Dimensional Space to Precision Medicine - mapping the Immune System in Multiple Sclerosis

Fabienne Brilot, Prof PhD (Sydney): MOGAD - the next Challenges

Falk Nimmerjahn, Prof PhD (Erlangen): Immunglobulin G as a Therapeutic for Autoimmunity – from cytotoxic Activity to Immunomodulation

Habib Ganjgahi, PhD (Oxford): Big data modelling on MS: probabilistic Machine Learning and generative AI approaches

Isaak Quast, PhD (Monash): Regulation of B cell Responses by Cytokines and Antibodies

Johanna Oechtering, MD (Basel): The Role of IgM and Complement in Multiple Sclerosis

Jon Laman, Prof MD (Groningen): CD40 Ligand Immunotherapy of MS from Animal Model to Phase 3 Trials 

Kevin Rostásy, Prof MD (Datteln): MOGAD - Spectrum Disorder in Children

Manuel Comabella, MD PhD (Barcelona): Interaction between human cytomegalovirus and Epstein-Barr virus in multiple sclerosis

Viktoria Wagner, PhD (Stanford): MiRNAs as potential regulators of the aging phenotype and promising novel therapy targets for age-related diseases

If you have any questions or comments regarding the Lecture Series, please feel free to contact us at
📧 Ambassadors

Powered by

Alexion Pharmaceuticals*
Argenx*
Bayer**
Hexal AG / Sandoz International GmbH*
Merck Group*
Novartis*
Roche**

*1 year
**single lectures
Listing on the website and display of the logo before and after the presentations